期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫内膜癌血管生成的研究进展 被引量：2

下载PDF
导出
摘要 子宫内膜癌的发展过程中有血管生成。微血管密度 (MVD)是衡量血管生成的定量指标 ,与内膜癌的预后有关 ,是判定预后的可靠独立指标。子宫内膜癌的血管生成与VEGF、FGF等促血管生长因子有关。雌、孕激素及某些治疗可调节VEGF和FGF的表达及血管生成 。
作者 姚晓奕 张晓菁 温泽清
机构地区 山东省交通医院妇产科 山东省立医院妇产科
出处 《现代妇产科进展》 CSCD 2003年第5期379-381,共3页 Progress in Obstetrics and Gynecology
关键词 子宫内膜肿瘤 新生血管化 病理性 血管内皮细胞生长因子 成纤维细胞生长因子
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Salvesen HB, Akslen LA. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas [J] .Int J Cancer, 1999,84:538-43.
  • 2Fujimoto J, Hori M, Ichigo S,et al.Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1,2, and 4) mRNA in well-differentiated endometrial cancer cells[J]. Eur J Gynecol Oncol, 1997, 18:497-501.
  • 3Konerding MA, Fait E, Dimitropoulou C, et al. Impact of fibroblast growth factor-2 on tumor microvvscular architecture. A tridimensional morphometric study [J]. Am J Pathol, 1998,152:1607-1616.
  • 4Siegfried S,Pekonen F, Nyman T, et al. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma[J] .Cancer, 1997,79:1166-1171.
  • 5Wagatsuma S, Konno R, Sato S, et al. Tumor angiogenesis, hepatocyte gowth factor,and c-Met expression in endometrial carcinoma[J]. Cancer, 1998,82:520-530.
  • 6Fujiwald R, Hata K, lida K,et al. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer[J]. Gynecol Oncol, 1998,68:247-Z52.
  • 7Fujimoto J, Sakaguchi H, Hirese R, et al. Progestins suppress estrogen-induced expression of vascular endothelial gowth factor (VEGF) subtypes in uterine endometrial cancer cell [J].Cancer Lett,1999,141:63-71.]
  • 8Hydex SM, Murthy L, Stancel GM. Progestin regulation of vascular endothelial growth factor in human breast cancer cells[J] .Cancer Res, 1998,58:392-395.
  • 9Hartford AC, Gohongi T, Fuhanum D, et al. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction[J]. Cancer Res,2000, 60:2128-2131.
  • 10Presta M, Rusnati M, Belleri M, et al. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process[J] .Cancer Res, 1999,59:2417-2424.

同被引文献7

  • 1杨丹,韩立敏.1969-2003年子宫内膜癌发病率及发病因素分析[J].复旦学报（医学版）,2005,32(4):479-480. 被引量：33
  • 2虞斌,许培箴,王秋伟,周红,周洪兴.肿瘤特异性生长因子在子宫内膜癌的应用价值[J].中国现代医学杂志,2005,15(14):2199-2201. 被引量：6
  • 3Fine BA ,Valente PT, Feinstein GI, et al, VEGF, flt21, and KDR/flk21 as prognostic indicators in endometrial carcinoma[J]. Gynecol Oncol,2000,76:33-39.
  • 4Egeblad M, Werb Z, New functions for the matrix metalloproteinases in cancer progression[J]. Nat Rev Cancer,2002,2(3) :161- 174.
  • 5Lopata A, Agresta F. Quinn MA, et al. Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity[J]. Gynecol Oncol,2003,90(2) :318-324.
  • 6Misugi F. SumiT. Okamoto E, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis[J]. Int J Mol Med,2005,16 (4) : 541-546.
  • 7Fine BA, Valente PT, Feinstein GI, et al. VEGF, flt21, and KDR/flk21 as prognostic indicators in endometrial carcinoma [ J]. Gynecol Oncol, 2000,76( 1 ) :33-39.

引证文献2

二级引证文献3

现代妇产科进展
2003年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部